Carson Wealth (CWM LLC)
GYRE icon

Carson Wealth (CWM LLC)’s Gyre Therapeutics GYRE Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$725 Buy
104
+68
+189% +$528 ﹤0.01% 5441
2025
Q4 		$0 Sell
36
-7
-16% -$54 ﹤0.01% 5466
2025
Q3 		$0 Sell
43
-80
-65% -$607 ﹤0.01% 5383
2025
Q2 		$1K Sell
123
-14
-10% -$122 ﹤0.01% 5008
2025
Q1 		$1K Buy
137
+122
+813% +$1.34K ﹤0.01% 4910
2024
Q4 		$0 Sell
15
-15
-50% -$192 ﹤0.01% 5002
2024
Q3 		$0 Buy
+30
New +$387 ﹤0.01% 4952

Other funds holding GYRE

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Carson Wealth (CWM LLC)'s GYRE Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Gyre Therapeutics (GYRE) stake by 189% in Q1 2026, buying an estimated $528 and bringing the position to 104 shares worth $725. The position accounts for ﹤0.01% of the portfolio, ranked #5441.

Carson Wealth (CWM LLC) first reported a position in GYRE in Q3 2024 and has held it in 7 quarters since. The position peaked at $1K in Q2 2025. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

  • Carson Wealth (CWM LLC) held 104 shares of Gyre Therapeutics worth $725 as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 68 Gyre Therapeutics shares in Q1 2026, an estimated $528.
  • Gyre Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5441 holding.
  • Carson Wealth (CWM LLC) first reported a position in Gyre Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Carson Wealth (CWM LLC)'s Gyre Therapeutics position peaked at $1K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.